Cargando…

Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection

Detalles Bibliográficos
Autores principales:	Kemmner, Stephan, Guba, Markus O., Schönermarck, Ulf, Stangl, Manfred, Fischereder, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270808/ https://www.ncbi.nlm.nih.gov/pubmed/32505466 http://dx.doi.org/10.1016/j.kint.2020.05.024

Ejemplares similares

Disqualification of Donor and Recipient Candidates From the Living Kidney Donation Program: Experience of a Single-Center in Germany
por: Grigorescu, Melissa, et al.
Publicado: (2022)

Corrigendum: Disqualification of donor and recipient candidates from the living kidney donation program: Experience of a single-center in Germany
por: Grigorescu, Melissa, et al.
Publicado: (2022)

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation
por: Schönermarck, Ulf, et al.
Publicado: (2011)

Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience
por: Kauke, Teresa, et al.
Publicado: (2016)

The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
por: Sommerer, Claudia, et al.
Publicado: (2014)

Calcineurin Inhibitors and Neutropenia: Is Cyclosporine Superior to Tacrolimus?
por: Duggal, Tanu, et al.
Publicado: (2019)

Calcineurin inhibitor toxicity in a renal transplant recipient
por: Charney, Douglas A., et al.
Publicado: (2009)

Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity
por: Gooch, Jennifer L., et al.
Publicado: (2017)

Severe Acute Kidney Injury in Cardiovascular Surgery: Thrombotic Microangiopathy as a Differential Diagnosis to Ischemia Reperfusion Injury. A Retrospective Study
por: Grigorescu, Melissa, et al.
Publicado: (2020)

Immunosuppressive calcineurin inhibitor cyclosporine A induces proapoptotic endoplasmic reticulum stress in renal tubular cells
por: Yilmaz, Duygu Elif, et al.
Publicado: (2022)

Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats
por: Brosda, Jan, et al.
Publicado: (2020)

Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuit
por: Seibt, Tobias, et al.
Publicado: (2014)

Effect of gene polymorphisms on the levels of calcineurin inhibitors in Indian renal transplant recipients
por: Ashavaid, T., et al.
Publicado: (2010)

High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
por: Sharma, Akhil, et al.
Publicado: (2019)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)
por: Hasmann, Sandra, et al.
Publicado: (2021)

Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model
por: Zakerkish, F, et al.
Publicado: (2021)

Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome
por: Tatapudi, Vasishta S., et al.
Publicado: (2018)

Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A
por: Niemczyk, Mariusz
Publicado: (2013)

Rare Presentations of Cytomegalovirus Infection in Renal Allograft Recipients
por: Ardalan, Mohammadreza
Publicado: (2012)

Nontubercular Mycobacterial Infection in a Renal Allograft Recipient
por: Anandh, U., et al.
Publicado: (2017)

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023)

Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
por: Leyking, Sarah, et al.
Publicado: (2015)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
por: Sayilar, Emel Isiktas, et al.
Publicado: (2022)

Zygomycosis in a renal allograft recipient
por: Lakshminarayana, G., et al.
Publicado: (2009)

Mycobacterial disease in renal allograft recipients
por: Ardalan, Mohammad-Reza
Publicado: (2013)

Chromoblastomycosis in a renal allograft recipient
por: Sooraj, Y. S., et al.
Publicado: (2013)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models
por: Shen, Xiujin, et al.
Publicado: (2016)

Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling
por: Rodrigues-Diez, Raquel, et al.
Publicado: (2016)

Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study
por: Sabbatini, Massimo, et al.
Publicado: (2014)

Correlation between gene polymorphism and blood concentration of calcineurin inhibitors in renal transplant recipients: An overview of systematic reviews
por: Su, Lan, et al.
Publicado: (2019)

Association Between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients
por: Oreschak, Kris, et al.
Publicado: (2021)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Pulmonary histoplasmosis in a renal allograft recipient
por: Lobo, V., et al.
Publicado: (2014)

Adefovir nephrotoxicity in a renal allograft recipient
por: George, N., et al.
Publicado: (2015)

Tophaceous gout in a renal allograft recipient
por: Chuang, Sung-Hua, et al.
Publicado: (2010)

Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis
por: Kong, Yuan, et al.
Publicado: (2011)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
por: Huh, Kyungmin, et al.
Publicado: (2013)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ubbpgg3qf9ngl38sgg1khqbbk